Black Diamond Therapeutics sold more shares than initially planned, and topped its targeted price range, raising $201M from its #IPO. Proceeds will support a Phase 1-ready #cancer drug, as well as further development of its pipeline https://xconomy.com/boston/2020/01/30/black-diamonds-upsized-ipo-raises-201m-to-advance-its-cancer-drug-rd/ … $BDTX
0 replies
0 proslijeđenih tweetova
2 korisnika označavaju da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.